Patient Controlled Remifentanil Analgesia for Normal Labour
NCT ID: NCT04541719
Last Updated: 2020-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE2
INTERVENTIONAL
2017-04-01
2018-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparison Study of Patient Controlled Epidural Analgesia (PCEA) With and Without Basal Infusion Using Ropivacaine 0,15% and Fentanyl μg/ml for Pain Relief in Labor, Assessment of Efficacy and Maternal Satisfaction.
NCT02084589
Role of the Single-shot Spinal Analgesia to Control Labour Pain
NCT02800694
Efficacy and Safety of Intravenous Paracetamol in Manament of Labour Pain
NCT04744727
Continuous Remote Vital Sign Monitoring During Labour Analgesia With Remifentanil
NCT07167498
Patient-controlled Intravenous Analgesia With Remifentanil Infusion for Labour
NCT01563939
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Peripartum analgesia
* Overall patient's satisfaction
* Maternal adverse effects
* Neonatal outcomes
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient-controlled remifentanil analgesia
Patients will received Patient-controlled remifentanil analgesia starting from labour pain until delivery
Patient-controlled remifentanil analgesia
Patient controlled remifentanil analgesia with a regimen to provide a bolus of 40 μg remifentanil with a lockout interval of 2 min
Epidural analgesia
Patients will received continuous epidural analgesia starting from labour pain until delivery
Epidural analgesia
Patients will receive continuous epidural analgesia using bupivacaine 0.125% in conjunction with fentanyl 2 ug/ml at a rate of 8-15 ml/hr
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient-controlled remifentanil analgesia
Patient controlled remifentanil analgesia with a regimen to provide a bolus of 40 μg remifentanil with a lockout interval of 2 min
Epidural analgesia
Patients will receive continuous epidural analgesia using bupivacaine 0.125% in conjunction with fentanyl 2 ug/ml at a rate of 8-15 ml/hr
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists physical class I to III
Exclusion Criteria
* Contraindications to epidural analgesia
* Non consented parturients
* Communications barriers.
* Intrauterine foetal growth retardation
* Foetal distress
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Alexandria University
OTHER
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed R El Tahan
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nabil A Abd El Raouf, MD
Role: STUDY_CHAIR
Professor in Cardiothoracic Ananesthesia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansoura University Hospitals
Al Mansurah, DK, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MFM-XYZ-2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.